Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Risedronic Acid + Calcium Ion + Vitamin D3
Deadline - Nov 10, 2024
GT reference number - 73088858
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 73088858
Document Type - Tender Notices
Description - Section 130a Paragraph 8 SGB V enables health insurance companies (KK) and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory KK. GWQ acts as a company for efficiency an d quality at KK in accordance with Section 130a Paragraph 8 Sentence 5 SGBV for its shareholders and customer funds. With regard to the relevant legal regulations for the awarding of public contracts, a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by GWQ ServicePlus AG. Until new drug discount agreements come into force, the GWQ would like to conclude dru
Gt Ref Id - 73088858
Deadline - Nov 10, 2024
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database